Поиск

Материалов:
1 005 012

Репозиториев:
30

Авторов:
596 024

Автор

Ключевое слово

Тип статьи

DOI

ORCID

Дополнительно:

Период публикации

Репозиторий

По вашему запросу найдено документов: 1005012

Страница 1 из 100502

Rationale for dapagliflozin administration for the prevention of adverse outcomes in patients with heart failure with reduced ejection fraction. Expert consensus statement

Tereshchenko S.N., Shestakova M.V., Ageev F.T., Galstyan G.R., Galyavich A.S., Glezer M.G., Zhirov I.V., Karpov Y.A., Kobalava Z.D., Matskeplishvili S.T.

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

Motloch, L.J., Jirak, Peter, Mirna, Moritz, Fiedler, Lukas, Davtyan, P.A., Lakman, I.A., Gareeva, D.F., Tyurin, A.V., Gumerov, R.M., Matskeplishvili, S.T., Pavlov, V.N., Cai, Benzhi, Kopp, Kristena, Topf, Alberta, Hoppe, Uta C., Pistulli, Rudini, Zagidullin, N.S.

, Tyurin, Gumerov, Matskeplishvili, Pavlov, Cai, Kopp, Topf, Hoppe, Pistulli and Zagidullin.

Pharmacological approaches to cardio-renal syndrome: A role for the inodilator levosimendan

Fedele Francesco

Pericapillary Edema Assessment by Means of the Nailfold Capillaroscopy and Laser Scanning Microscopy

Yakimov Boris P.

Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study

Use of levosimendan in acute heart failure

Harjola Veli Pekka

Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus

[Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)"].

[Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)].

The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations

Nieminen Markku S.

Страница 1 из 100502